Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Heligenics Launches Innovative Precision Prescription Test to Enhance Breast Cancer Therapeutics
In a significant development, biotech company Heligenics has introduced a groundbreaking precision genetic test designed to aid in the selection of drugs for breast cancer treatment. This test is the first of its kind and aims to address the issue of drug resistance commonly observed in breast cancer patients....
Thermo Fisher Scientific Granted FDA Clearance for Groundbreaking Immunoassays Facilitating Preeclampsia Risk Assessment
Thermo Fisher Scientific, a leading global provider of scientific solutions, has announced that its novel immunoassays, the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR biomarkers, have received clearance from the U.S. Food and Drug Administration (FDA)....
Olverembatinib, a Novel Drug Developed by Ascentage Pharma, Recommended for Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST
Ascentage Pharma, a biopharmaceutical company focused on developing novel therapies for cancer and other diseases, has announced that the China National Medical Products Administration's Center for Drug Evaluation (CDE) has recommended their lead drug candidate, olverembatinib (HQP1351), for Breakthrough Therapy Designation (BTD). The BTD recommendation is for the treatment of patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumor (GIST) who have received initial treatment....
Game-Changing Breakthrough in Pharma: Speedata's Chip Revolutionizes Drug Discovery, Accelerating Complex Pharmaceutical Workload from 90 Hours to 19 Minutes in Simulation
Speedata, a company specializing in Analytics Processing Unit (APU) technology, has announced a groundbreaking achievement in the pharmaceutical industry. They conducted a simulation of their APU on a compound similarity analysis workload, yielding remarkable results. While the analysis typically required 90 hours when processed on a CPU, Speedata's APU completed it in just 19 minutes, marking a significant improvement of 280 times in speed....
Lantern Pharma and Bielefeld University Collaborate on Breakthrough Antibody Drug Conjugates (ADCs) using AI Platform RADR®
Lantern Pharma has announced a collaboration with Bielefeld University to develop innovative antibody-drug conjugates (ADCs) using their AI platform, RADR®. This collaboration will be led by Professor Norbert Sewald, an expert in cryptophycin synthesis and ADC development, and the coordinator of the "Magicbullet::reloaded" consortium....
Sania Therapeutics Emerges to Advance Novel Therapies for Neural Circuit Dysfunction
Sania Therapeutics has recently emerged from stealth mode and made significant progress in the field of genetic medicines for neural circuit dysfunction. The company presented key proof-of-concept data at the ASGCT 2023 conference while introducing its proprietary patented platforms....
GSK Launches First RSV Vaccine for Older Adults
GSK has revealed Arexvy, the first adjuvanted vaccination for respiratory syncytial virus (RSV), which is specifically developed to prevent RSV-related lower respiratory tract disease (LRTD) in older individuals....
New Drug for NASH with Liver Fibrosis Treatment Launched
Madrigal Pharmaceuticals, Inc. has recently introduced resmetirom, a groundbreaking drug designed to treat individuals diagnosed with nonalcoholic steatohepatitis (NASH) accompanied by liver fibrosis....
Breakthrough Drug for Treatment of Candidemia, Invasive Candidiasis Patients
Cidara Therapeutics and Melinta Therapeutics have collaborated to launch REZZAYO™ (rezafungin for injection) for the treatment of candidemia and invasive candidiasis in people who have limited or no other therapeutic choices....
Deciphera Pharmaceuticals Introduces Novel Drug in NCCN Guidelines
Deciphera Pharmaceuticals has recently announced the addition of its innovative drug, QINLOCK® (ripretinib), to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology....
